Clinical Trial Update: Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser Ablation [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating GLYC-101 for outcomes after laser ablation in wounds; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wounds

Drugs mentioned

• GLYC-101

Snippet

Sponsor: TR Therapeutics | Conditions: Wounds | Phase 2 | Status: COMPLETED | Results posted: 2011-07-25